Review: Dipeptidyl peptidase-4 inhibitors do not increase overall adverse events in type 2 diabetes

被引：2
|
作者：
Chatterjee, Saurav [1 ,2 ]
Chatterjee, Sanjay [3 ]
机构：
[1] Brown Univ, Providence, RI 02912 USA
[2] Providence VAMC, Providence, RI USA
[3] Apollo Gleneagles Hosp, Kolkata, W Bengal, India
来源：
ANNALS OF INTERNAL MEDICINE | 2013年 / 158卷 / 08期
关键词：
METAANALYSIS;
D O I：
10.7326/0003-4819-158-8-201304160-02008
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Dipeptidyl Peptidase-4 Inhibitors Do Not Increase the Risk of Cardiovascular Events in Type 2 Diabetes
    Kim, Seoyoung C.
    Glynn, Robert
    Liu, Jun
    Everett, Brendan
    Goldfine, Allison
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 188 - 189
  • [2] In type 2 diabetes, dipeptidyl peptidase-4 inhibitors do not increase pancreatitis
    Morey-Vargas, Oscar L.
    Montori, Victor M.
    ANNALS OF INTERNAL MEDICINE, 2014, 160 (02)
  • [3] Dipeptidyl peptidase-4 inhibitors do not increase the risk of cardiovascular events in type 2 diabetes: a cohort study
    Seoyoung C. Kim
    Robert J. Glynn
    Jun Liu
    Brendan M. Everett
    Allison B. Goldfine
    Acta Diabetologica, 2014, 51 : 1015 - 1023
  • [4] Dipeptidyl peptidase-4 inhibitors do not increase the risk of cardiovascular events in type 2 diabetes: a cohort study
    Kim, Seoyoung C.
    Glynn, Robert J.
    Liu, Jun
    Everett, Brendan M.
    Goldfine, Allison B.
    ACTA DIABETOLOGICA, 2014, 51 (06) : 1015 - 1023
  • [5] Do Dipeptidyl Peptidase-4 Inhibitors Increase the Risk of Heart Failure in Patients with Type 2 Diabetes?
    Hassanabad, Mortaza Fatehi
    Hassanabad, Ali Fatehi
    Fatehi, Mohammad
    CURRENT DIABETES REVIEWS, 2022, 18 (08)
  • [6] Dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes: a comparative review
    Deacon, C. F.
    DIABETES OBESITY & METABOLISM, 2011, 13 (01): : 7 - 18
  • [7] Dipeptidyl Peptidase-4 Inhibitors Do Not Increase the Risk of Cardiovascular Events in Type 2 Diabetes: A Population-Based Cohort Study
    Kim, Seoyoung C.
    Glynn, Robert
    Liu, Jun
    Everett, Brendan M.
    Goldfine, Allison B.
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [8] Pharmacogenetics of dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes mellitus: A review
    Samoilova, Iuliia G.
    Vaizova, Olga E.
    Stankova, Anastasia E.
    Matveeva, Mariia, V
    Podchinenova, Daria, V
    Kudlay, Dmitry A.
    Borozinets, Anastasiia A.
    Filippova, Tatyana A.
    Grishkevich, Ivan R.
    Partala, Anastasia, V
    Gerasimova, Diana A.
    TERAPEVTICHESKII ARKHIV, 2024, 96 (01) : 63 - 67
  • [9] Cost Effectiveness of Dipeptidyl Peptidase-4 Inhibitors for Type 2 Diabetes
    Jinsong Geng
    Hao Yu
    Yiwei Mao
    Peng Zhang
    Yingyao Chen
    PharmacoEconomics, 2015, 33 : 581 - 597
  • [10] Dipeptidyl peptidase-4 inhibitors: their role in the management of type 2 diabetes
    Mkele, Gail
    JOURNAL OF ENDOCRINOLOGY METABOLISM AND DIABETES OF SOUTH AFRICA, 2015, 20 (01) : 64 - 66
12345